HOME >> BIOLOGY >> NEWS
Targeted Genetics, M.D. Anderson Cancer Center And University Of Pittsburgh,,Report Phase I Clinical Trial Results Of Gene Therapy Treatment For Cancer

-- Research Subject of Press Conference at 89th Annual American Association for Cancer Research (AACR) Conference --

New Orleans, LA, March 30, 1998 - Targeted Genetics Corporation (Nasdaq: TGEN) today announced Phase I results of its E1A gene therapy for the treatment of breast and ovarian cancers at a press conference at the 89th Annual Meeting of the American Association for Cancer Research (AACR). Targeted Genetics research was selected as one of approximately 40 from a field of over 4500 abstracts to be highlighted by the AACR.

In a presentation titled "Phase I E1A gene therapy in patients with advanced breast and ovarian cancers," researchers demonstrated that they delivered and expressed an E1A gene in both diseased and normal human cells using a proprietary non-viral liposomal delivery mechanism. E1A is a tumor inhibitor gene. Previous laboratory and animal studies have demonstrated E1A's ability to suppress metastases, induce apoptosis (programmed cell death) and reverse the overexpression of HER-2/neu, a cancer-causing gene. In patients with cancer, overexpression of the HER-2/neu oncogene is correlated with poor prognoses, increased tumor formation and metastasis and resistance to chemotherapeutic agents.

Naoto T. Ueno, M.D., Instructor, Gabriel N. Hortobagyi, M.D., Chairperson of the Department of Breast Medical Oncology, and Mien-Chie Hung, Ph.D., Deputy Chairman of the Department of Tumor Biology and Director of the Breast Cancer Basic Research Program, all of the University of Texas M. D. Anderson Cancer Center in Houston, TX, along with colleagues at Targeted Genetics and the University of Pittsburgh, conducted the research presented at AACR.

"This study is significant because we have demonstrated that we can deliver the E1A gene to human cancer cells and see a subsequent biological effect," said Naoto T. Ueno, M.D. "Although these results are preliminary, we believe that overexpression of
'"/>

Contact: Amy Flood
a.flood@noonanrusso.com
212-696-4455, x. 211
Noonan/Russo Communications
30-Mar-1998


Page: 1 2 3

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. Targeted therapy for lung cancer patients shows promise in extending lives
3. Targeted immunotherapy eradicates cancer in mice
4. Targeted radiation to liver tumors spares tissue, improves quality of life
5. Targeted Genetics presents data on arthritis gene therapy
6. Targeted genetics presents promising data from cystic fibrosis clinical trial
7. Targeted Genetics presents clinical data on E1A cancer gene therapy
8. Targeted Genetics presents advances in systemic gene delivery technology
9. Targeted Genetics presents advances in synthetic gene delivery technologies
10. Ribozyme Pharmaceuticals, Inc. Demonstrates Potent Activity Of A Ribozyme Targeted Against The Hepatitis C Virus
11. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 21, 2020 , ... ... background and medical screening, announces the launch of a testing service aimed ... safe. The new service is provided by ClearStar’s Medical Information Services (“MIS”) ...
(Date:5/21/2020)... ... May 20, 2020 , ... Catalent, the ... biologics, cell and gene therapies, and consumer health products, today announced that Jean-François ... presenting at the ISCT 2020 Paris Virtual conference, which takes place on 28 ...
(Date:5/21/2020)... ... May 21, 2020 , ... Agility Orthopedics, home to ... Boston area, is pleased to announce a partnership with Dallas-based Simple Interact to ... in the area, Agility Orthopedics is focused on speeding up patient workflows to ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... , ... June 29, 2020 , ... ... to competitively procured purchasing contracts to its membership, recently named BioFit Engineered ... members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and ...
(Date:6/28/2020)... (PRWEB) , ... June 26, 2020 , ... ... association representing security solutions providers, today announced its strong opposition to the recently ... bill would impose a blanket ban on most federal use of nearly all ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... therapies, today announced that it has filed an Investigational New Drug application (IND) ... clinical trial of its lead drug candidate NBTX-001 in patients with panic disorder ...
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has been ... the Paris Agreement to stock market dips, ways to reduce CO2 is something we ... their portfolio. Most of the biofuels being produced today are created from recycled cooking ...
Breaking Biology Technology:
Cached News: